Services

Driving Innovation, De-Risking Investment, and Accelerating Growth

At PlexoA, we empower biotech startups, investors, and innovation-driven enterprises with strategic insights and actionable solutions. Our expertise spans market research, R&D due diligence, and business development, ensuring that cutting-edge science translates into commercial success.

We offer both project-based consulting and long-term advisory services, helping clients navigate scientific, financial, and commercial complexities with confidence.

Our Suite of Productized Services

Biotech Deal Validator
Validate opportunities before investing.
A due diligence service that rapidly assesses the scientific, regulatory, and commercial viability of biotech assets or companies to support confident investment or partnership decisions.

Pre-clinical Strategy Accelerator
From concept to IND and/or CTA—smarter, faster.
Expert-driven design and execution of preclinical plans that align with regulatory, clinical, and commercial success—reducing risk and increasing speed to clinic.

Biotech Partnering Pathfinder
Find the right partners at the right time.
A strategic matchmaking and deal-readiness service that identifies ideal pharma or biotech partners, prepares compelling deal materials, and guides term sheet negotiation.

Biotech Asset Blueprint Builder
De-risk and define your asset’s path.
A structured framework to clarify a biotech asset’s full potential, challenges, and inflection points—helping founders or investors position it for funding, licensing, or acquisition.

Biotech Growth Booster
Scale your biotech smarter.
Operational and strategic guidance to help growing biotech companies optimize their pipeline, expand leadership, secure capital, and strengthen their investor story.

Our Core Expertise

At the heart of every PlexoA engagement is deep, actionable expertise in three core domains: R&D Due Diligence, Market Research, and Business Development. These pillars power all five PlexoA services, ensuring every client decision is evidence-based, market-aligned, and strategically sound.

R&D Due Diligence

De-risk your investments with science-backed insights

We conduct comprehensive evaluations of emerging biotech innovations, assessing clinical feasibility, IP strength, regulatory pathways, and commercial potential to guide informed decision-making.

✅ Scientific & technical due diligence
✅ Competitive landscape & IP analysis
✅ Clinical & regulatory strategy evaluation

Market Research

Navigate the biotech landscape with data-driven insights

We provide in-depth market analysis, competitor benchmarking, and biotech industry trends to help you position your innovations effectively and capitalize on emerging opportunities.

✅ Market sizing & opportunity assessment
✅ Competitive positioning & differentiation
✅ Industry trends & emerging technologies

Business Development

Turn biotech innovation into commercial success

We help biotech companies build strategic partnerships, enhance visibility, drive market expansion, strengthen market positioning, and maximize revenue potential, ensuring sustained business growth.

✅ Go-to-market strategy
✅ Investor & partnership outreach
✅ Client acquisition & branding strategy

How We Do R&D due diligence: Our Proven Approach

At PlexoA, we combine deep scientific expertise with strategic insight to deliver high-impact biotech R&D due diligence. Our process is designed to uncover value, surface risks, and enable confident decision-making across investments, M&A, and licensing.

I. Rapid Triage & Fit Assessment

✅ Quick evaluation of scientific rationale, asset maturity, and strategic fit.

✅ Prioritize high-potential opportunities and flag early concerns.

II. Deep-Dive Technical & Scientific Review

✅ In-depth analysis of preclinical/clinical data, study design, and translational relevance.

✅ Critical assessment of technology platforms, mechanisms, and IP landscape.

III. Market & Competitive Intelligence

✅ Benchmark against competitors and current standards of care.

✅ Evaluate commercial positioning, differentiation, and unmet need.

IV. Regulatory & Development Pathway

✅ Assess regulatory strategy, filings, and agency feedback.

✅ Map development timelines, inflection points, and risks.

V. Risk Mapping & Strategic Insights

✅ Identify scientific, technical, and operational red flags.

✅ Deliver clear, actionable insights aligned with your business objectives.

Outcome:

A rigorous, investor- and partner-ready assessment that supports smarter deals, faster decisions, and long-term value creation.

Empowering Biotech Innovation with Strategic R&D Expertise

Discover how PlexoA has helped biotech innovators, investors, and enterprises achieve growth, strategic breakthroughs, and lasting impact through expert guidance and collaboration.

PlexoA’s team gave us exactly what we needed—a clear, science-backed view of the opportunity. Their due diligence helped us move forward with confidence.

Client 1

Managing Partner, Life Sciences Venture Capital Firm

If you’re a biotech startup trying to scale, PlexoA should be your first call. Their network, advice, and business know-how helped us land key partnerships and stand out in the market.

Client 4

COO, Biopharma Scale-Up

Unlock tailored solutions with our flexible pricing models

Explore the best pricing options for your business by contacting us.

For VC, Angel Investors & Financial Firms

R&D Due Diligence, Scientific Asset Assessment, and Strategic Investment Support

For Biotech Startups, CROs, Research Labs, and beyond

Scientific Strategy, Study Design, Connecting Dots, and Communication Support

Start your journey with PlexoA today and discover how we can help you drive success!